US 6924362
Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
expired A61KA61K2039/505A61P
Quick answer
US patent 6924362 (Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/16, A61P31/12